Who Paid My Doc
Amyvid
Drug Neuroscience
NDC 0002-1200-50
General payments
$236,691
Research payments
$54,664,630
Through program year 2025, $236,691 in general payments and $54,664,630 in research payments were reported against Amyvid (Neuroscience).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $54,365,430 | 145 |
| 2023 | General | $170,598 | 8,968 |
| 2022 | General | $60,978 | 3,294 |
| 2021 | General | $209 | 5 |
| 2020 | General | $3,000 | 2 |
| 2020 | Research | $112,200 | 1 |
| 2019 | General | $1,906 | 4 |
| 2019 | Research | $187,000 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.
The top 5 of 88 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 44 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
12,273 general · 147 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.